Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Key Business Regulations to Consider While Arranging Your Independent venture- Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
- Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
- South African army arrive in crime hotspots to help tackle gangs
- Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Flourishing in a Remote Workplace: Individual Techniques
- BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- Discussion on deployment of foreign troops ongoing, two sources tell 'Post'
